During the past decade, Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Diabetic Macular Edema" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" in a lesser frequency.

Most popular intervention types in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Aflibercept" (1 trials), "Faricimab" (1 trials), "No intervention" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".